News

GENTIS has officially launched the Sperm DNA test, which quantifies the percentage of fragmented sperm DNA based on dye color changes using flow cytometry (analyzing up to 10,000 sperm cells). This test helps explain recurrent miscarriages, unexplained infertility, and failed IVF attempts in couples. Notably, this test is cost-effective, making it accessible to all men.

On November 11, 2023, Ho Chi Minh City Society for Reproductive Medicine (HOSREM) organized a colloquium on Preimplantation Genetic Testing at the Caravelle Saigon Hotel. GENTIS was honored to be the main sponsor and to participate in presenting at the event, contributing to its overall success.

The Pre-implantation Genetic Testing Symposium will be held at 8 AM on Saturday, November 11, 2023, at Caravelle Saigon Hotel.

On the morning of October 26th, the Hanoi Tax Department convened the "Commendation of Exemplary Taxpayers in the Capital City for 2022" conference. GENTIS was honored as one of the outstanding taxpaying enterprises that made substantial contributions to the national and social budget over the year of 2022.

On October 25-26, 2023, GENTIS organized a commemoration to mark the 13th anniversary of the company's establishment (October 26, 2010 - October 26, 2023) in the coastal city of Ha Long. The anniversary program served as GENTIS' sincere expression of gratitude to the Valued Partners, Valued Customers, and all of its employees.

Preeclampsia is a dangerous medical syndrome that appears after the 20th week of pregnancy. For pregnant women, preeclampsia can cause hypertensive complications, kidney failure, liver damage, coagulation disorders, and life-threatening eclampsia.

From October 14 to 18, 2023, the ASRM 2023 Scientific Congress & Expo officially took place in New Orleans, Louisiana. GENTIS was represented at ASRM 2023 by Mr. Do Manh Ha – CEO, Mr. Pham Dinh Minh – Director of R&D, and Mr. Nguyen Quang Vinh – Director of the Testing Center.

In the field of reproductive assistance, selecting an IVF embryo for implantation into the uterus should not solely rely on morphology but also on genetic information obtained through testing. This ensures the selection of high-quality preimplantation embryos and increases the chances of a successful pregnancy. PGT-M is performed on embryos to detect genetic disorders caused by pre-identified gene mutations or clear family history.